Soedra Aelvsborg Hospital Vaestra Goetalandsregionen

At Södra Älvsborgs sjukhus, Borås, Kliniska prövningsenheten, a major share of the research focuses on neoplasms and blood cancers, including breast cancer, multiple myeloma, lymphoma, and leukemia. These studies are mainly designed to test new treatment combinations, compare them with current standards, and improve long-term disease control.

• New treatment strategies for breast cancer, including HER2-positive, triple-negative, and hormone receptor–positive disease
• Therapy optimization in multiple myeloma and relapsed or refractory myeloma
• Research in follicular lymphoma, diffuse large B-cell lymphoma, and chronic lymphocytic leukemia
• Comparisons of newer targeted and immune-based approaches with established care

The site is active in studies that aim to improve response rates, extend remission, and refine treatment choices for patients with complex cancers.

Another important area at this hospital is bacterial infections and virus diseases, with trials addressing difficult-to-treat urinary tract infections, bloodstream infections, and tick-borne illness. The goal is often to find more effective antibiotics, safer step-down treatments, or better ways to guide infection management.

• Studies on febrile urinary tract infection and infections caused by resistant bacteria
• Research on periprosthetic joint infection and Staphylococcus aureus bacteraemia
• Evaluation of treatment options for tick-borne encephalitis
• Work aimed at improving antibiotic selection and reducing relapse

These trials support better infection care by comparing treatment effectiveness and helping clinicians choose therapies that are both practical and safe.

The site also conducts studies in cardiovascular diseases, nutritional and metabolic diseases, and related kidney conditions. Research here includes prevention of stroke, management of atrial fibrillation, and treatment strategies for people with type 2 diabetes, hypertension, and established heart disease.

• Stroke prevention and bleeding-risk balancing in atrial fibrillation
• Trials in high cardiovascular risk and coronary heart disease prevention
• Studies in type 2 diabetes with coexisting heart and kidney disease
• Research on therapies that may reduce major cardiovascular events

These investigations aim to improve everyday care for patients with overlapping heart, metabolic, and kidney problems.

Clinical trial activity at the site includes immune system diseases, allergic disease, and other inflammatory disorders such as rheumatoid arthritis, SLE, and psoriatic arthritis. The research is focused on testing therapies that may reduce symptoms, control inflammation, and improve long-term disease stability.

• Studies in grass allergy and allergic rhinitis
• Research in rheumatoid arthritis, SLE, and related autoimmune conditions
• Trials exploring better control of chronic immune-mediated inflammation
• Evaluation of treatment approaches intended to improve quality of life

This area reflects a strong interest in personalized and symptom-focused care for patients living with persistent immune-related disease.

Research at Soedra Aelvsborg Hospital Vaestra Goetalandsregionen also spans hormonal diseases, nervous system diseases, and female urogenital diseases and pregnancy complications. The trials include diabetes-related work, treatment of nerve-related conditions, and studies aimed at improving care during pregnancy and after childbirth.

• Studies in type 1 diabetes and type 2 diabetes
• Research on facial nerve palsy and vestibular neuritis
• Trials related to labour induction and women’s health care
• Work assessing whether treatments can improve recovery and reduce symptoms

These projects are designed to support better diagnosis, recovery, and treatment selection across several common clinical areas.

The trial portfolio also includes studies that do not fit a single disease category, showing a broad clinical research profile across the hospital. This includes investigations of medication safety, individualized dosing, and treatment discontinuation after prolonged benefit.

• Studies on tamoxifen dosing and treatment continuation after breast cancer
• Research on immune recovery after childhood cancer treatment
• Trials examining medication transfer into breast milk and treatment safety in special populations
• Projects evaluating when therapy can be safely reduced or stopped

These studies highlight a practical focus on improving treatment tolerability, tailoring care to individual patients, and supporting safer clinical decision-making.